FDA announcements

FDA Authorizes Updated Novavax COVID-19 Vaccine for Ages 12 and Older

Aug 30, 2024, 06:43 PM

The U.S. Food and Drug Administration (FDA) has granted emergency use authorization for an updated Novavax COVID-19 vaccine. This vaccine is authorized for individuals aged 12 years and older. The updated vaccine is designed to more closely target currently circulating variants, aiming to provide better protection against serious outcomes of COVID-19, such as hospitalization and death. This authorization offers an alternative to mRNA vaccines, expanding the options available for COVID-19 vaccination.